Training in noncommunicable diseases epidemiological, data science and Implementation Science research to strengthen evidence-based interventions, policy and control in Uganda. - Non-communicable diseases (NCDs), particularly cardiovascular disease, diabetes, and chronic lung conditions, represent a catastrophic public health and economic crisis in the United States, driving over 75% of the nation’s multi-trillion-dollar healthcare expenditure. Domestically and globally, these conditions are accelerating at an unprecedented rate, fueled by shared structural and lifestyle risk factors including demographic shifts, rapid urbanization, sedentary habits, and aging populations. To combat this escalating burden, this D43 renewal application supports strengthening advanced, multidisciplinary training in epidemiological methods, modern health data science, and implementation science research for NCDs in Uganda. Conducting this collaborative research training program within Uganda offers an extraordinary and irreplaceable scientific environment that is fundamentally unavailable within the United States. Uganda presents a unique public health landscape characterized by distinct population dynamics, high-density lifespans, genetic diversities, and critical disease etiologies, most notably the complex, emerging biomedical interactions where chronic NCDs intersect with a high baseline of treated, aging infectious diseases like HIV and tuberculosis. This specific low-resource, high-burden clinical environment serves as an ideal training ground to observe, model, and analyze disease progressions and health system bottlenecks under conditions of extreme scarcity. By expanding our existing training framework to integrate advanced data science, bioinformatics, and scalable predictive modeling, this program equips a premium cohort of Ugandan and collaborative US researchers with the analytical competencies required to untangle massive, complex healthcare datasets. The data-driven methodologies, clinical algorithms, and cost-effective implementation strategies co-developed through this partnership will be directly translational to American health. They provide US health systems with highly transferable insights to optimize resource allocation, refine preventative protocols, and drastically lower morbidity, mortality, and clinical operational costs within various American populations. Furthermore, this renewal directly expands vital international research pipelines, creating unprecedented, secure field-research opportunities, bidirectional data-sharing networks, and joint global health clinical trial platforms for US investigators and their institutions. Ultimately, this program significantly deepens institutional ties, accelerates reciprocal scientific discovery, safeguards global health security, and firmly advances the National Institutes of Health (NIH) mission to protect and improve human health worldwide, including for all Americans.
